Paul Tudor Jones’s Amgen AMGN Stock Holding History

Paul Tudor Jones’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.9M	Buy	159,800 +136,300	+580%	+$46.7M	0.08%	180
2026 Q1	$8.27M	Buy	23,500 +3,000	+15%	+$1.07M	0.02%	851
2025 Q4	$6.71M	Sell	20,500 -35,900	-64%	-$11.4M	0.01%	976
2025 Q3	$15.9M	Buy	56,400 +13,100	+30%	+$3.8M	0.03%	546
2025 Q2	$12.1M	Buy	43,300 +42,000	+3,231%	+$11.9M	0.03%	569
2025 Q1	$405K	Buy	1,300 +100	+8%	+$29.5K	﹤0.01%	2403
2024 Q4	$313K	Sell	1,200 -4,200	-78%	-$1.25M	﹤0.01%	2554
2024 Q3	$1.74M	Hold	5,400	–	–	0.01%	1281
2024 Q2	$1.69M	Buy	+5,400	New	+$1.59M	0.01%	1173

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Paul Tudor Jones's AMGN Position: Q4 2025 in Review

Paul Tudor Jones sold out of Amgen (AMGN) in Q4 2025, closing a stake of 119,834 shares — an estimated $38M sold.

Paul Tudor Jones first reported a position in AMGN in Q2 2013 and held it in 34 quarters. The position peaked at $46.7M in Q1 2024. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

Paul Tudor Jones reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
Paul Tudor Jones sold 119,834 Amgen shares in Q4 2025, an estimated $38M.
Paul Tudor Jones first reported a position in Amgen in Q2 2013 and held it in 34 quarters.
Paul Tudor Jones's Amgen position peaked at $46.7M in Q1 2024.
3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.